SUMMARY It has been proposed that anti-inflammatory actions of corticosteroids rely on promotion of a natural peptide phospholipase A2 inhibitor, lipocortin, but in vivo effects on arachidonic acid metabolism have not been shown. Equilibrium dialysis of the rectum in patients with ulcerative colitis was used to determine whether cyclooxygenase and lipoxygenase products released from the inflamed rectal mucosa could be differentially inhibited by systemic treatment with prednisolone and indomethacin, respectively. In 10 patients with severe disease luminal concentrations of prostaglandin E2, prostaglandin F2a, and leucotriene B4 were markedly raised (p<0-05) on comparison with 10 healthy controls, and they decreased significantly (p<0-05) within 72 hours after administration of prednisolone 1-5 mg/kg/day orally. In contrast prostaglandin, but not leucotriene B4 concentrations decreased (p<0-05) within 72 hours after administration of indomethacin 150 mg/day in another 10 patients with distal disease. These prompt reductions in concentrations of arachidonic acid metabolites more likely are caused by direct drug actions, rather than being secondary to decreased tissue damage. The data accord with the theory explaining antiinflammatory effects of corticosteroids through lipocortin activity and support the belief that leucotrienes are more important than prostaglandins as mediators of inflammation in ulcerative colitis.
Administration of pharmacologic doses of corticosteroids is one of the therapeutic mainstays in the treatment of a large number of inflammatory and immunologically mediated diseases. Despite their widespread use it has not been possible to conceptualise their anti-inflammatory mechanisms in any single model,'2 although increasing lines of investigation are concerned with a modulation of the arachidonic acid cascade. Arachidonic acid is released from cellular phospholipids by the activity of various phospholipases' and is subsequently metabolised either through the cyclooxygenase pathway4 to prostaglandins, prostacyclin and thromboxanes or through the lipoxygenase pathways' to hydroxyperoxyeicosatetraenoic acids, hydroxyeicosatetraenoic acids, and leucotrienes. These oxygenation products play a central role -both in the expression of the efferent limb of immune based inflammatory responses and in acute inflammatory responses where specific immunity plays no primary role6-by acting as mediators of pain, fever, increased vascular permeability, or oedema formation and as modulators of numerous aspects of lymphocyte and phagocytic cell function.7 Unlike aspirin and other non-steroidal anti-inflammatory compounds, which block the cyclooxygenase pathway,' the corticosteroids do not inhibit arachidonic acid metabolism in cell free systems."' In contrast, these drugs are considered to inhibit phospholipase activity in viable cells"'2 by promoting the synthesis of a natural 1095 phospholipase A2 inhibitor, commonly denoted as lipocortin." Although this action of corticosteroids, in high doses at least, seems fairly reproducible in various in vitro systems and in some experimental models of inflammation in animals, its relevance for the in vivo condition in man remains unsettled. Furthermore, in recent studies the administration of pharmacologic doses of corticosteroids did not affect the total body prostanoid synthesis in the normal condition.'4" We therefore studied whether cyclooxygenase-and lipoxygenase products released from inflamed rectal mucosa'" in patients with ulcerative colitis could be promptly -that is, within 72 hours, and differentially inhibited by orally administered prednisolone and the cyclooxygenase inhibitor, indomethacin, respectively. Considering the difficulties inherent in the choice of an experimental design, which prevents non-specific stimulation of arachidonic acid release and metabolism,'7 we applied the method of in vivo dialysis of rectum'6 to provide the most reliable index of the balance between local synthesis and degradation in vivo.
Methods

SUBJECTS
The study comprised 10 consecutive inpatients (four men and six women, aged (Table) . Leucotriene B4 concentrations were significantly more raised (p<0 05) in patients with severe disease (Table) than in patients with distally located disease. Conversely, the concentrations of prostaglandins were not different between the groups of patients. Figure 1 shows a significant decrease (Wilcoxon's matched-pairs-signed-ranks test, p<005) in luminal concentrations of cyclooxygenase and lipoxygenase products in the rectum from patients with ulcerative colitis within 72 hours of starting prednisolone treatment. The clinical condition improved gradually in all cases during the continued hospitalisation and the dose of prednisolone was gradually tapered.
During indomethacin administration luminal con-Effects oforally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis 1097 (Fig. 2) . Counting of returned indomethacin capsules was consistent with the stipulated prescription and serum indomethacin concentrations ranged from 0-24-2-13 .tg/ml (median . Because corticosteroids are the most effective drugs in ulcerative colitis2" it is tempting to ascribe the antiinflammatory mechanism to the observed effect of the drug on arachidonic acid metabolites. This is consistent with the observation that leucotriene B4 is a powerful chemotactic agent,28 which has been shown in increased amounts in scraped colonic mucosa from patients with ulcerative colitis. 29 We have previously found that luminal concentrations of prostaglandin E2 and leucotriene B4 were positively correlated to disease activity in patients with distally located ulcerative colitis and decreased toward control levels at. two or four weeks in the patients who had responded to treatment."' The reports that indomethacin is without therapeutic efficacy in ulcerative colitis25 2h and the present observations of more increased concentrations of leucotrien B4 in patients with severe disease, in addition to the prompt decrease after prednisolone, substantiate the belief9 that leucotrienes may be more important than prostaglandins as mediators of inflammation in ulcerative colitis.
The present data on the effects of prednisolone on stimulated arachidonic acid metabolism accord with the molecular theory of an anti-inflammatory action through inhibition of phospholipase A2'12 mediated by lipocortin, a 40 kD protein, the structure of which is now known.' In addition to being derived from phosphatidylcholine and phosphatidylethanolamine by the activation of phospholipase A2, arachidonic acid is released from inositol phospholipids, via two consecutive reactions catalysed by phospholipase C and diacylglycerol lipase.3'32 Our data make it tempting, therefore, to suggest that phosphatidylinositol turnover is the major source of arachidonic acid in the normal condition, where total body production of prostaglandins appears unaffected by corticosteroids,'4 15 whereas the action of phospholipase A2 is a major determinant of arachidonic acid metabolism in the inflamed tissue. 
